Legal & General Group
RIGL icon

Legal & General Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Legal & General Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107K Sell
3,951
-263
-6% -$8.84K ﹤0.01% 2604
2025
Q4 		$180K Sell
4,214
-72
-2% -$2.71K ﹤0.01% 2592
2025
Q3 		$121K Sell
4,286
-24
-0.6% -$718 ﹤0.01% 2629
2025
Q2 		$80.7K Buy
4,310
+2,442
+131% +$46.3K ﹤0.01% 2659
2025
Q1 		$33.6K Buy
1,868
+176
+10% +$3.57K ﹤0.01% 2783
2024
Q4 		$28.5K Sell
1,692
-59
-3% -$1.13K ﹤0.01% 2906
2024
Q3 		$28.3K Hold
1,751
– – ﹤0.01% 2912
2024
Q2 		$14.4K Sell
1,751
-2
-0.1% -$21 ﹤0.01% 3159
2024
Q1 		$25.9K Hold
1,753
– – ﹤0.01% 2880
2023
Q4 		$25.5K Sell
1,753
-116
-6% -$1.19K ﹤0.01% 2937
2023
Q3 		$20.2K Sell
1,869
-203
-10% -$2.44K ﹤0.01% 3023
2023
Q2 		$26.7K Sell
2,072
-94
-4% -$1.27K ﹤0.01% 2986
2023
Q1 		$28.6K Hold
2,166
– – ﹤0.01% 2973
2022
Q4 		$32.6K Sell
2,166
-4,245
-66% -$38.9K ﹤0.01% 3030
2022
Q3 		$76K Buy
6,411
+147
+2% +$1.99K ﹤0.01% 2890
2022
Q2 		$71K Sell
6,264
-458
-7% -$9.2K ﹤0.01% 2933
2022
Q1 		$201K Buy
6,722
+1
+0% +$27 ﹤0.01% 2664
2021
Q4 		$179K Buy
6,721
+416
+7% +$12.6K ﹤0.01% 2764
2021
Q3 		$229K Buy
6,305
+3,339
+113% +$131K ﹤0.01% 2645
2021
Q2 		$129K Buy
2,966
+200
+7% +$7.55K ﹤0.01% 2659
2021
Q1 		$95K Buy
2,766
+386
+16% +$15.3K ﹤0.01% 2638
2020
Q4 		$83K Hold
2,380
– – ﹤0.01% 2638
2020
Q3 		$57K Sell
2,380
-735
-24% -$18K ﹤0.01% 2650
2020
Q2 		$57K Buy
3,115
+300
+11% +$5.4K ﹤0.01% 2692
2020
Q1 		$44K Sell
2,815
-799
-22% -$17K ﹤0.01% 2635
2019
Q4 		$78K Buy
3,614
+595
+20% +$12.3K ﹤0.01% 2675
2019
Q3 		$57K Hold
3,019
– – ﹤0.01% 2693
2019
Q2 		$79K Hold
3,019
– – ﹤0.01% 2610
2019
Q1 		$78K Hold
3,019
– – ﹤0.01% 2567
2018
Q4 		$69K Buy
3,019
+250
+9% +$7.05K ﹤0.01% 2575
2018
Q3 		$89K Hold
2,769
– – ﹤0.01% 2548
2018
Q2 		$79K Buy
2,769
+142
+5% +$5.05K ﹤0.01% 2565
2018
Q1 		$93K Sell
2,627
-938
-26% -$37.5K ﹤0.01% 2496
2017
Q4 		$137K Buy
3,565
+504
+16% +$19.2K ﹤0.01% 2455
2017
Q3 		$76K Hold
3,061
– – ﹤0.01% 2768
2017
Q2 		$84K Buy
3,061
+418
+16% +$11.4K ﹤0.01% 2694
2017
Q1 		$88K Sell
2,643
-106
-4% -$2.7K ﹤0.01% 2611
2016
Q4 		$66K Buy
2,749
+1,219
+80% +$34.9K ﹤0.01% 2791
2016
Q3 		$54K Sell
1,530
-201
-12% -$5.76K ﹤0.01% 2486
2016
Q2 		$37K Hold
1,731
– – ﹤0.01% 2625
2016
Q1 		$35K Hold
1,731
– – ﹤0.01% 2551
2015
Q4 		$53K Hold
1,731
– – ﹤0.01% 2434
2015
Q3 		$42K Hold
1,731
– – ﹤0.01% 2536
2015
Q2 		$52K Hold
1,731
– – ﹤0.01% 2522
2015
Q1 		$62K Hold
1,731
– – ﹤0.01% 2377
2014
Q4 		$40K Hold
1,731
– – ﹤0.01% 2532
2014
Q3 		$35K Buy
+1,731
New +$48.9K ﹤0.01% 2540

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legal & General Group's RIGL Position: Q1 2026 in Review

Legal & General Group reduced its Rigel Pharmaceuticals (RIGL) stake by 6.2% in Q1 2026, selling an estimated $8.84K and leaving 3,951 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #2604.

Legal & General Group first reported a position in RIGL in Q3 2014 and has held it in 47 quarters since. The position peaked at $229K in Q3 2021. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Legal & General Group held 3,951 shares of Rigel Pharmaceuticals worth $107K as of Q1 2026.
  • Legal & General Group sold 263 Rigel Pharmaceuticals shares in Q1 2026, an estimated $8.84K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2604 holding.
  • Legal & General Group first reported a position in Rigel Pharmaceuticals in Q3 2014 and has held it in 47 quarters since.
  • Legal & General Group's Rigel Pharmaceuticals position peaked at $229K in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.